Prognostic factors for overall survival of conventional osteosarcoma of the appendicular skeleton

被引:0
|
作者
Mthethwa, P. G. [1 ]
Marais, L. C. [2 ]
Aldous, C. M. [3 ]
机构
[1] Univ KwaZulu Natal, Dr Pixley Ka Isaka Seme Mem Hosp, Nelson Mandela Sch Clin Med, Dept Orthopaed Surg, Durban, South Africa
[2] Univ KwaZulu Natal, Coll Hlth Sci, Nelson Mandela Sch Clin Med, Acad Head Dept Orthopaed Surg, Durban, South Africa
[3] Univ KwaZulu Natal, Coll Hlth Sci, Sch Clin Med, Dept Clin Med, Durban, South Africa
来源
BONE & JOINT OPEN | 2024年 / 5卷 / 03期
关键词
OUTCOMES; LIMB;
D O I
10.1302/2633-1462.53.BJO-2023-0159.R1
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Prognostic factors for overall survival of conventional osteosarcoma of the appendicular skeletonAims The aim of this study is to determine the predictors of overall survival (OS) and predictive factors of poor prognosis of conventional high-grade osteosarcoma of the limbs in a single -centre in South Africa. Methods We performed a retrospective cross-sectional analysis to identify the prognostic factors that predict the OS of patients with histologically confirmed high-grade conventional osteosarcoma of the limbs over ten years. We employed the Cox proportional regression model and the Kaplan -Meier method for statistical analysis. Results This study comprised 77 patients at a three-year minimum follow-up. The predictors of poor OS were: the median age of <= 19 years (hazard ratio (HR) 0.96; 95% confidence interval (CI) 0.92 to 0.99; p = 0.021); median duration of symptoms >= five months (HR 0.91; 95% CI 0.83 to 0.99; p < 0.037); metastasis at diagnosis (i.e. Enneking stage III) (HR 3.33; 95% CI 1.81 to 6.00; p < 0.001); increased alkaline phosphatase (HR 3.28; 95% CI 1.33 to 8.11; p < 0.010); palliative treatment (HR 7.27; 95% CI 2.69 to 19.70); p < 0.001); and amputation (HR 3.71; 95% CI 1.12 to 12.25; p < 0.032). In contrast, definitive surgery (HR 0.11; 95% CI 0.03 to 0.38; p < 0.001) and curative treatment (HR 0.18; 95% CI 0.10 to 0.33; p < 0.001) were a protective factor. The Kaplan -Meier median survival time was 24 months, with OS of 57.1% at the three years. The projected five-year event -free survival was 10.3% and OS of 29.8% (HR 0.76; 95% CI 0.52 to 1.12; p = 0.128). Conclusion In this series of high-grade conventional osteosarcoma of the appendicular skeleton from South Africa, 58.4% (n = 45) had detectable metastases at presentation; hence, an impoverished OS of five years was 29.8%. Large-scale future research is needed to validate our results.
引用
收藏
页码:210 / 217
页数:8
相关论文
共 50 条
  • [1] Prognostic factors in canine appendicular osteosarcoma - a meta-analysis
    Boerman, Ilse
    Selvarajah, Gayathri T.
    Nielen, Mirjam
    Kirpensteijn, Jolle
    BMC VETERINARY RESEARCH, 2012, 8
  • [2] Prognostic factors in canine appendicular osteosarcoma – a meta-analysis
    Ilse Boerman
    Gayathri T Selvarajah
    Mirjam Nielen
    Jolle Kirpensteijn
    BMC Veterinary Research, 8
  • [3] Metastatic bone disease: A review of survival, prognostic factors and outcomes following surgical treatment of the appendicular skeleton
    Kirkinis, M. N.
    Lyne, C. J.
    Wilson, M. D.
    Choong, P. F. M.
    EJSO, 2016, 42 (12): : 1787 - 1797
  • [4] Ewing family tumors of the appendicular skeleton: a retrospective analysis of prognostic factors
    Muratori, Francesco
    Foschi, Lorenzo
    Roselli, Giuliana
    Frenos, Filippo
    Tamburini, Angela
    Palomba, Annarita
    Greto, Daniela
    Loi, Mauro
    Beltrami, Giovanni
    Capanna, Rodolfo
    Mondanelli, Nicola
    Campanacci, Domenico Andrea
    EUROPEAN JOURNAL OF ORTHOPAEDIC SURGERY AND TRAUMATOLOGY, 2021, 31 (08): : 1557 - 1565
  • [5] Ewing family tumors of the appendicular skeleton: a retrospective analysis of prognostic factors
    Francesco Muratori
    Lorenzo Foschi
    Giuliana Roselli
    Filippo Frenos
    Angela Tamburini
    Annarita Palomba
    Daniela Greto
    Mauro Loi
    Giovanni Beltrami
    Rodolfo Capanna
    Nicola Mondanelli
    Domenico Andrea Campanacci
    European Journal of Orthopaedic Surgery & Traumatology, 2021, 31 : 1557 - 1565
  • [6] Prognostic factors to survival of patients with chondroblastic osteosarcoma
    Sun, Hui-Hui
    Chen, Xiang-Yang
    Cui, Jia-Qu
    Zhou, Zhao-Ming
    Guo, Kai-Jin
    MEDICINE, 2018, 97 (39)
  • [7] PROGNOSTIC FACTORS ON OVERALL SURVIVAL IN ENDOMETRIAL CANCER
    Orlandini, E.
    Branes, J.
    Majerson, D.
    Saez, N.
    Roger, G.
    Cuello, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 1048 - 1050
  • [8] INCREASED SURVIVAL, LIMB PRESERVATION, AND PROGNOSTIC FACTORS FOR OSTEOSARCOMA
    PETRILLI, AS
    GENTIL, FC
    EPELMAN, S
    LOPES, LF
    BIANCHI, A
    LOPES, A
    FIGUEIREDO, MTD
    MARQUES, E
    DEBELLIS, N
    CONSENTINO, E
    PROSPERO, D
    DECAMARGO, OP
    OLIVEIRA, NR
    FRANCO, E
    JAFFE, N
    CANCER, 1991, 68 (04) : 733 - 737
  • [9] Survival and prognostic factors in conventional central chondrosarcoma
    Fromm, Julian
    Klein, Alexander
    Baur-Melnyk, Andrea
    Knoesel, Thomas
    Lindner, Lars
    Birkenmaier, Christof
    Roeder, Falk
    Jansson, Volkmar
    Duerr, Hans Roland
    BMC CANCER, 2018, 18
  • [10] Survival and prognostic factors in conventional central chondrosarcoma
    Julian Fromm
    Alexander Klein
    Andrea Baur-Melnyk
    Thomas Knösel
    Lars Lindner
    Christof Birkenmaier
    Falk Roeder
    Volkmar Jansson
    Hans Roland Dürr
    BMC Cancer, 18